Topics
- Life cycle management
- Strengths and limitations associated with biobanking
- Implementation of lean methods in biobanking
- Biospecimen processing, storage and transportation
- Biorepository management
- Regulations governing biobanks, global standardisation and quality assurance
- The use of biobanks and biospecimens in cancer research
- Ethical issues surrounding participant informed consent
- Utilization of biospecimens for drug research and development
- High quality samples in research towards personalised medicines and increased drug safety
- New trends in outsourcing
- Biobanking UK 2013 for academic institutes, hospitals and pharma companies
- Developments in virtual biobanking
- The role of social networking in biobanking
Who should Attend
Managers, executives, Consultants and Researchers involved in Tissue bank, Biobank, Biological Sample Management, Biorepository, Clinical Genetics, Molecular Diagnostics, Histopathology, Pathology, Data Privacy Office, Genomics, Clinical Research, Scientific and Quality, Laboratory and Inventory, R&D, Strategic Outsourcing, Quality Control, Personalised Medicine, Translational Medicine, Bioinformatics, Pharmacogenetics, Business Development, Bioanalytical Chemistry and Strategic Alliances.
